Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

desantis

More than half of US states will relax lockdowns by the end of the week

April 30, 2020
Business Services COVID-19, Lockdown, coronavirus, quaratine

Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …

News
gilead-speeds-manufacture-of-experimental-covid-19-drug-biospace-4-5-20-495x350

Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients

April 30, 2020
Research and Development COVID-19, Gilead, coronavirus, remdesivir

The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …

News
facemask

Men most likely to exhibit the worst COVID-19 symptoms, according to a new study

April 30, 2020
Business Services COVID-19, coronavirus

Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …

News
aussss

Australia calls for investigation into China’s coronavirus response

April 29, 2020
Research and Development Australia, COVID-19, China, coronavirus

Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …

News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

April 29, 2020
Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine

Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …

News

Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey

April 28, 2020
Manufacturing and Production COVID-19, coronavirus, survey

Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …

News
pharmafocus_may_2020_cover

The May 2020 issue of Pharmafocus is available to read free online now!

April 28, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!

News
korean

South Korean researchers start testing pancreatitis drug in COVID-19 patients

April 28, 2020
Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …

News
children_with_mask

12 British children hospitalised with rare condition linked to COVID-19

April 28, 2020
Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus

12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …

News
italy_lockdown

Italy to relax COVID-19 lockdown in early May

April 27, 2020
Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus

Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …

News
researchers

Researchers studying heartburn drug as potential coronavirus treatment

April 27, 2020
Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic

Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …

News
hazmat

‘Excess deaths’ in England among the highest in Europe

April 27, 2020
Sales and Marketing COVID-19, coronavirus, deaths, pandemic

English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …

News
images_1

FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine

April 27, 2020
Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …

News
gilead-sciences

Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial

April 24, 2020
Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

April 24, 2020
Medical Communications COVID-19, coronavirus, top 10

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026